(Q113368879)

density

1.35 gram per cubic centimetre

unknown value

1 reference

Warfarin™ (English)

31 July 2022

11 September 2022

melting point

322±1 degree Fahrenheit

1 reference

uncertainty corresponds to

161 degree Celsius

1 reference

31 July 2022

Warfarin (English)

162±1 degree Celsius

1 reference

Warfarin™ (English)

31 July 2022

11 September 2022

surface tension

72.8 millinewton per metre

20 degree Celsius

1 reference

Warfarin™ (English)

31 July 2022

11 September 2022

vapor pressure

0.09±0.01 millimetre of mercury

71±1 degree Fahrenheit

1 reference

solubility

0.002±0.001 gram per 100 gram of solvent

68±1 degree Fahrenheit

solvent

water

1 reference

17 milligram per litre

solvent

water

20 degree Celsius

1 reference

31 July 2022

Warfarin (English)

54.6 gram per litre

20 degree Celsius

1 reference

Warfarin™ (English)

31 July 2022

11 September 2022

16.9 gram per litre

20 degree Celsius

1 reference

Warfarin™ (English)

31 July 2022

11 September 2022

22.2 gram per litre

20 degree Celsius

1 reference

Warfarin™ (English)

31 July 2022

11 September 2022

partition coefficient water/octanol

2.70

unknown value

1 reference

31 July 2022

Warfarin (English)

0.7

32.5±2.5 degree Celsius

1 reference

Warfarin™ (English)

31 July 2022

11 September 2022

pKa

5

time-weighted average exposure limit

unknown value

1 reference

31 July 2022

Warfarin (English)

NIOSH Pocket Guide ID

0665

0 references

0.1±0.1 milligram per cubic metre

applies to jurisdiction

United States of America

duration

10±1 hour

1 reference

immediately dangerous to life or health

100±10 milligram per cubic metre

1 reference

defined daily dose

7.5 milligram

1 reference

https://www.whocc.no/atc_ddd_index/?code=B01AA03

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

warfarin (English)

1 reference

Warfarin (English)

medical condition treated

19 January 2016

1 reference

13 December 2016

2 references

13 December 2016

postoperative complications

2 October 2018

1 reference

13 December 2016

1 reference

13 December 2016

2 references

13 December 2016

2 October 2018

heart disease

1 reference

2 October 2018

heart valve disease

1 reference

2 October 2018

atrial flutter

1 reference

2 October 2018

thrombosis

1 reference

transient cerebral isolation

2 October 2018

1 reference

significant drug interaction

2 October 2018

1 reference

1 reference

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

rosuvastatin

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

simvastatin

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

amiodarone

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

fluconazole

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

miconazole

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

voriconazole

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

carbamazepin

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

gemfibrozil

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

fenofibrate

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

celecoxib

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

Diclofenac

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

diflunisal

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

(RS)-etodolac

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

(RS)-fenoprofen

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

(+-)-flurbiprofen

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

ibuprofen

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

(RS)-ketoprofen

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

ketorolac

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

mefenamic acid

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

meloxicam

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

nabumetone

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

naproxen

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

oxaprozin

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

piroxicam

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

sulfamethoxazole

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

metronidazole

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

sulindac

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

tolmetin

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

L-thyroxine

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

liothyronine sodium

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

liotrix

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

indomethacin

1 reference

https://www.crediblemeds.org/healthcare-providers/drug-drug-interaction

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urokinase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alteplase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenecteplase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Streptokinase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibrutinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imatinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tetracycline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

minocycline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

demeclocycline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

doxycycline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxytetracycline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ceftriaxone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

D-glucosamine

increased blood clotting time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tigecycline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

capecitabine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-tegafur

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluorouracil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paracetamol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tamoxifen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

danazol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

gemfibrozil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

voriconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norfloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atazanavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levofloxacin hemihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

saquinavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ciprofloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

disulfiram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-miconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

DL-ofloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cimetidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

D-glucosamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mercaptopurine hydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azathioprine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

A reference set of clinically relevant adverse drug-drug interactions

carbamazepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamcinolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rosuvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rosuvastatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fenofibrate

increased blood clotting time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

efavirenz

decreased international normalised ratio

1 reference

A reference set of clinically relevant adverse drug-drug interactions

efavirenz

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rifampicin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bezafibrate

increased blood clotting time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aprepitant

decreased international normalised ratio

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aprepitant

shortened prothrombin time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Vitamin K epoxide reductase complex subunit 1

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6853

17 August 2016

route of administration

oral administration

0 references

intravenous injection

0 references

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category D

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category X

1 reference

imported from Wikimedia project

1 reference

subject has role

anticoagulant

1 reference

15 March 2018

1 reference

MeSH descriptor ID

D014859

15 March 2018

developmental toxicant

start time

1 July 1987

1 reference

California Proposition 65 list of chemicals

19 March 2020

https://oehha.ca.gov/chemicals/warfarin

has part(s)

(S)-warfarin

proportion

0.5

0 references

(R)-warfarin

proportion

0.5

0 references

different from

(RS)-warfarin

criterion used

racemate and a group of stereoisomers (structure with undefined spatial configuration) should be described in different items

0 references

Commons category

Warfarin

0 references

Identifiers

NL CR AUT ID

ph127493

subject named as

warfarin

0 references

ChEBI ID

10033

mapping relation type

0 references

0 references

GN4550000

0 references

ZVG number

35400

1 reference

imported from Wikimedia project

1 reference

Hazardous Substances Data Bank

28 October 2019

WARFARIN (English)

10 May 2021

0 references

0 references

201-377-6

1 reference

warfarin (English)

ECHA Substance Infocard ID

19 November 2016

100.001.253

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Warfarin (English)

CAS no.: 81-81-2 (English)

AGROVOC ID

c_8299

0 references

AICS Chemical ID (BEING DELETED)

0 references

1 reference

World Health Organisation international non-proprietary name numeric ID

Warfarin (English)

publication date

17 November 2015

341

0 references

Guide to Pharmacology Ligand ID

6853

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6853

D03.383.663.283.446.520.914

warfarin (English)

19 November 2016

Warfarin

0 references

MeSH tree code

1 reference

D03.633.100.150.446.520.914

MeSH descriptor ID

D014859

1 reference

1 reference

warfarin (English)

19 November 2016

1 reference

Warfarin (English)

Human Metabolome Database ID

4 October 2016

0 references

1 reference

warfarin (English)

MedlinePlus drug identifier

19 November 2016

a682277

0 references

PatientsLikeMe treatment ID

0 references

1 reference

warfarin (English)

19 November 2016

1 reference

California Proposition 65 list of chemicals

Warfarin (English)

19 January 2016

1 reference

7 January 2020

https://oehha.ca.gov/chemicals/warfarin

DeCS ID

15261

0 references

electronic Essential Medicines List medicine ID

128

1 reference

https://list.essentialmeds.org/medicines/128

eEML - Electronic Essential Medicines List (English)

Encyclopædia Britannica Online ID

23 October 2021

science/warfarin

subject named as

warfarin

0 references

1 reference

28 October 2013

Gran Enciclopèdia Catalana ID

warfarina

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0 references

0 references

1 reference

9 July 2020

Microsoft Academic ID

0 references

0 references

0 references

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

C2909255381

reason for deprecated rank

applies to other chemical entity

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

0 references

ScienceDirect topic ID

agricultural-and-biological-sciences/warfarin

0 references

chemistry/warfarin

0 references

medicine-and-dentistry/warfarin

0 references

neuroscience/warfarin

0 references

nursing-and-health-professions/warfarin

0 references

pharmacology-toxicology-and-pharmaceutical-science/warfarin

0 references

Store medisinske leksikon ID

warfarin

0 references

UK Parliament thesaurus ID

419909

subject named as

Warfarin

0 references

UMLS CUI

C0043031

1 reference

warfarin (English)

19 November 2016

0 references

WikiSkripta article ID

11547

0 references

WordNet 3.1 Synset ID

04558491-n

1 reference

varfariini

warfarin

1 reference

YSO-Wikidata mapping project